Search Press releases Keywords From To 16 Nov 2023 ‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements Read More 11 Nov 2023 Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels Read More 10 Nov 2023 UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe Read More 10 Nov 2023 UCB Presents New Five-Year Data on BIMZELX[®]▼(bimekizumab) in Ankylosing Spondylitis at ACR Convergence 2023 Read More 9 Nov 2023 UCB successfully completes its offer to the public of fixed rate notes and decides to early terminate the subscription period Read More 7 Nov 2023 UCB launches an offer to the public of 6-year 5.20% fixed rate notes in Belgium and in Luxembourg Read More Pagination First page Previous page Previous … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Page 26 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe